Corrigendum to “(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation” [Int. Immunopharmacol. 125(Part B) (2023) 111124] (International Immunopharmacology (2023) 125(PA), (S1567576923014509), (10.1016/j.intimp.2023.111124))

  • Boyoung Kim
  • , Ji Eun Yu
  • , In Jun Yeo
  • , Dong Ju Son
  • , Hee Pom Lee
  • , Yoon Seok Roh
  • , Key Hwan Lim
  • , Jaesuk Yun
  • , Hanseul Park
  • , Sang Bae Han
  • , Jin Tae Hong

Research output: Contribution to journalComment/debate

Abstract

The authors regret that an error was identified in Fig. 3(C) of the manuscript. The low magnification images for iNOS and COX-2 were incorrectly presented as identical. We would like to replace the incorrect low magnification image for COX-2 with the correct one.[Formula presented] The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number112543
JournalInternational Immunopharmacology
Volume137
DOIs
StatePublished - 20 Aug 2024

Fingerprint

Dive into the research topics of 'Corrigendum to “(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation” [Int. Immunopharmacol. 125(Part B) (2023) 111124] (International Immunopharmacology (2023) 125(PA), (S1567576923014509), (10.1016/j.intimp.2023.111124))'. Together they form a unique fingerprint.

Cite this